Jason V. Coloma, Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 6,643 shares at $26.20 ($174K) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($174k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.20 | 6,090 | $160K | 91.7% |
| 2 | $26.24 | 553 | $15K | 8.3% |
| Total | $26.20 avg | 6,643 | $174K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-05 | $922K | — | Filing → |
| MAZE | SELL | 2026-07-02 | $1.0M | — | Filing → |
| MAZE | SELL | 2026-06-24 | $725K | — | Filing → |